Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
---|---|
pe ratio | -7.38 |
peg ratio | 0.08 |
price to book ratio | 7.04 |
price to sales ratio | 12.45 |
enterprise value multiple | -10.96 |
price fair value | 7.04 |
profitability ratios | |
---|---|
gross profit margin | 92.11% |
operating profit margin | -166.82% |
pretax profit margin | -134.62% |
net profit margin | -133.54% |
return on assets | -22.32% |
return on equity | -71.11% |
return on capital employed | -44.32% |
liquidity ratio | |
---|---|
current ratio | 2.33 |
quick ratio | 2.33 |
cash ratio | 2.26 |
efficiency ratio | |
---|---|
days of inventory outstanding | 0.00 |
operating cycle | 26.68 |
days of payables outstanding | 8.03 |
cash conversion cycle | 18.65 |
receivables turnover | 13.68 |
payables turnover | 45.47 |
inventory turnover | 0.00 |
debt and solvency ratios | |
---|---|
debt ratio | 0.16 |
debt equity ratio | 0.70 |
long term debt to capitalization | 0.00 |
total debt to capitalization | 0.41 |
interest coverage | 109.82 |
cash flow to debt ratio | -1.88 |
cash flow ratios | |
---|---|
free cash flow per share | -0.45 |
cash per share | 1.09 |
operating cash flow per share | -0.40 |
free cash flow operating cash flow ratio | 1.13 |
cash flow coverage ratios | -1.88 |
short term coverage ratios | -7.23 |
capital expenditure coverage ratio | -7.85 |
Frequently Asked Questions
ProQR Therapeutics N.V. (PRQR) published its most recent earnings results on 07-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. ProQR Therapeutics N.V. (NASDAQ:PRQR)'s trailing twelve months ROE is -71.11%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. ProQR Therapeutics N.V. (PRQR) currently has a ROA of -22.32%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
PRQR reported a profit margin of -133.54% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.33 in the most recent quarter. The quick ratio stood at 2.33, with a Debt/Eq ratio of 0.70.